News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
11 28 2018 -- Provides outlook for 2019-2022, extending the company's targeted 3-5% revenue compound annual growth rate (CAGR) and updating its adjusted earnings goal to a 4-6% CAGRAt a meeting with analysts and investors at its Investor Day tomorrow, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...
-
11 28 2018 New lab to be the company's largest in country with more than 1,100 employees, featuring innovative design, automation and expanded capacityQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will build a flagship laboratory in Clifton, N.J. to enhance...
-
11 27 2018 Transaction aims to provide a broader range of clinical and pathology diagnostic services to patients, hospitals and physicians throughout Missouri and surrounding Midwestern statesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to acquire the assets of the clinical...
-
11 11 2018 The power of healthcare data gives rise to novel markers of cardiovascular disease and stroke in the earliest, preventable stagesCHICAGO, Nov.11, 2018 — Developing novel approaches to understand pre-disease and health is the cornerstone strategy of One Brave Idea™, a research initiative led by Dr. Calum MacRae, vice...
-
11 09 2018 New Findings Demonstrate the Benefit of Using Genetic Markers to Aid Detection of Atrial FibrillationQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of three studies at the 2018 American Heart Association...
-
11 08 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that MyQuest, used by more than six million people to see, store and share...
11 08 2018 - Quest to participate as in-network provider of laboratory services for Horizon Blue Cross Blue Shield of New Jersey plan participantsHorizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) announced today that it is expanding its laboratory network by adding Quest Diagnostics (NYSE: DGX) as an in-network provider of...
11 07 2018 QuestDirect Builds on Quest's existing consumer offerings available through the new and improved MyQuest patient platform that lets people access their lab results, schedule appointments and pay billsQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced the launch of QuestDirect, an enhanced consumer-initiated testing service...
-
11 06 2018 Oxford Immunotec's T-SPOT®.TB Tuberculosis and Accutix™ Tick-Borne Disease Testing Services are Part of Quest Diagnostics' Portfolio of Innovative Infectious Disease Diagnostics Tests, Broadening Access in the United StatesQuest Diagnostics (NYSE: DGX) and Oxford Immunotec Global PLC (Nasdaq: OXFD) today announced that Quest Diagnostics has completed its previously announced acquisition of the U.S. laboratory...
-
11 01 2018 Relationship ensures broad access to innovative FIT test in the U.S.Bridgewater, N.J., and Secaucus, N.J., Nov 1, 2018 – Clinical Genomics, a leading innovator of tests for colorectal cancer, and Quest Diagnostics (NYSE: DGX), the world's leading provider of...